CureVac N.V. (CVAC)
CureVac N.V. is a biotechnology company pioneering mRNA-based therapies and vaccines. Focused on infectious diseases and cancer, its growth is driven by partnerships, R&D, and advancements in RNA technology. Chart
MBX Biosciences, Inc. (MBX)
MBX Biosciences develops therapies for rare endocrine disorders. Its lead programs use innovative peptide technology, aiming to address unmet medical needs. Strategic investment and clinical progress drive growth. Chart
Stoke Therapeutics, Inc. (STOK)
Stoke Therapeutics focuses on RNA-based treatments for severe genetic diseases like Dravet syndrome. The company leverages proprietary technology to restore protein expression, with growth tied to clinical trials and new indications. Chart